ROYAL BANK OF CANADA - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$239,000
+42.3%
17,016
+4.7%
0.00%
Q2 2023$168,000
+14.3%
16,252
+2.7%
0.00%
Q1 2023$147,000
+11.4%
15,826
+6.3%
0.00%
Q4 2022$132,000
+6.5%
14,887
+0.0%
0.00%
Q3 2022$124,000
+1.6%
14,8820.0%0.00%
Q2 2022$122,000
-12.2%
14,882
-7.5%
0.00%
Q1 2022$139,000
-17.3%
16,080
-9.3%
0.00%
Q4 2021$168,000
-46.7%
17,726
-5.3%
0.00%
Q3 2021$315,000
+12.1%
18,726
+1.6%
0.00%
Q2 2021$281,000
-86.0%
18,428
-82.1%
0.00%
-100.0%
Q1 2021$2,011,000
+15.2%
103,215
+6.5%
0.00%0.0%
Q4 2020$1,746,000
-11.4%
96,904
-5.1%
0.00%0.0%
Q3 2020$1,970,000
-26.2%
102,119
-0.1%
0.00%0.0%
Q2 2020$2,669,000
+48.4%
102,197
+1.4%
0.00%0.0%
Q1 2020$1,799,000
-47.2%
100,813
-1.3%
0.00%0.0%
Q4 2019$3,409,000
+630.0%
102,143
+420.8%
0.00%
Q3 2019$467,000
-27.6%
19,611
+9.3%
0.00%
Q2 2019$645,000
+45.3%
17,939
+48.8%
0.00%
Q1 2019$444,000
+56.9%
12,058
+83.7%
0.00%
Q4 2018$283,000
-20.1%
6,563
-12.3%
0.00%
Q3 2018$354,000
+17.6%
7,483
+23.6%
0.00%
Q2 2018$301,000
+19.9%
6,056
+19.9%
0.00%
Q1 2018$251,000
+79.3%
5,052
+34.5%
0.00%
Q4 2017$140,000
+154.5%
3,755
+114.6%
0.00%
Q3 2017$55,0001,7500.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders